STAT3 promotes signaling through pro-oncogenic inflammatory pathways, such as NF-kB and gp130/Jak/STAT, leading to increased tumor cell proliferation, survival, and invasion while simultaneously suppressing antitumor immunity (Yu et al., 2009; Loh et al., 2019). Here, STAT3 is linked to neoplasm.